BONESUPPORT HOLDING AB (PUBL) – Publishes Q1 2020 Interim report
Lund, Sweden, 08.00 am CET, May 8 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries today publishes the interim report for the first quarter 2020. GOOD GROWTH BUT INFLUENCED BY COVID-19 “FDA's 'breakthrough device designation' for CERAMENT G is further proof of the unique therapeutic value of our antibiotic eluting products." Emil Billbäck, CEO JANUARY - MARCH 2020 · Net sales increased with 32 percent compared to previous year, and amounted to SEK 43.4 million (32.8). In March 2020, covid-19 reached a pandemic